The Asia Pacific aortic repair device market is projected to experience\u00a0robust\u00a0growth during the forecast period, fueled by rising endovascular procedure volumes, ongoing innovation in aortic stent graft technology and changes in the prices of the endovascular grafts. Nevertheless, several factors will partially constrain procedural growth, including insufficient numbers of physicians trained in endovascular methods, limited aneurysm awareness and screening programs, and budget-restricted healthcare infrastructure across select covered markets.<\/p>\n
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for aortic repair devices in Asia Pacific from 2019 to 2034.<\/p>\n","protected":false},"template":"","class_list":["post-585401","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-aortic-repair-devices","medtech-geography-asia-pacific","medtech-date-2294"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/585401","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=585401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}